Transarterial radioembolization with yttrium-90 of unresectable primary hepatic malignancy in children.

Background Primary malignant liver tumors are rare, accounting for 1% to 2% of all childhood cancers. When chemotherapy fails, transarterial radioembolization with yttrium-90 (TARE-Y90) may offer an alternative therapy as a bridge to surgical resection or liver transplant or for palliation.Methods W... View More